183 related articles for article (PubMed ID: 38692720)
21. Family cascade screening for equitable identification of familial hypercholesterolemia: study protocol for a hybrid effectiveness-implementation type III randomized controlled trial.
Johnson C; Chen J; McGowan MP; Tricou E; Card M; Pettit AR; Klaiman T; Rader DJ; Volpp KG; Beidas RS
Implement Sci; 2024 Apr; 19(1):30. PubMed ID: 38594685
[TBL] [Abstract][Full Text] [Related]
22. Integrated guidance to enhance the care of children and adolescents with familial hypercholesterolaemia: Practical advice for the community clinician.
Horton AE; Martin AC; Srinivasan S; Justo RN; Poplawski NK; Sullivan D; Brett T; Chow CK; Nicholls SJ; Pang J; Watts GF;
J Paediatr Child Health; 2022 Aug; 58(8):1297-1312. PubMed ID: 35837752
[TBL] [Abstract][Full Text] [Related]
23. Establishing a national screening programme for familial hypercholesterolaemia in Lithuania.
Petrulioniene Z; Gargalskaite U; Kutkiene S; Staigyte J; Cerkauskiene R; Laucevicius A
Atherosclerosis; 2018 Oct; 277():407-412. PubMed ID: 30270078
[TBL] [Abstract][Full Text] [Related]
24. Improving identification and management of familial hypercholesterolaemia in primary care: Pre- and post-intervention study.
Weng S; Kai J; Tranter J; Leonardi-Bee J; Qureshi N
Atherosclerosis; 2018 Jul; 274():54-60. PubMed ID: 29751285
[TBL] [Abstract][Full Text] [Related]
25. Implementation of an evidence-based model of care for low back pain in emergency departments: protocol for the Sydney Health Partners Emergency Department (SHaPED) trial.
Machado GC; Richards B; Needs C; Buchbinder R; Harris IA; Howard K; McCaffery K; Billot L; Edwards J; Rogan E; Facer R; Lord Cowell D; Maher CG;
BMJ Open; 2018 Apr; 8(4):e019052. PubMed ID: 29674362
[TBL] [Abstract][Full Text] [Related]
26. How do the experiences and beliefs of adults and children with heterozygous familial hypercholesterolaemia influence their adherence to treatment? A systematic review of qualitative evidence protocol.
Kinnear FJ; Perry R; Searle A; Hamilton-Shield JP; Lithander FE
Syst Rev; 2018 Aug; 7(1):120. PubMed ID: 30111381
[TBL] [Abstract][Full Text] [Related]
27. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.
Wiegman A; Gidding SS; Watts GF; Chapman MJ; Ginsberg HN; Cuchel M; Ose L; Averna M; Boileau C; Borén J; Bruckert E; Catapano AL; Defesche JC; Descamps OS; Hegele RA; Hovingh GK; Humphries SE; Kovanen PT; Kuivenhoven JA; Masana L; Nordestgaard BG; Pajukanta P; Parhofer KG; Raal FJ; Ray KK; Santos RD; Stalenhoef AF; Steinhagen-Thiessen E; Stroes ES; Taskinen MR; Tybjærg-Hansen A; Wiklund O;
Eur Heart J; 2015 Sep; 36(36):2425-37. PubMed ID: 26009596
[TBL] [Abstract][Full Text] [Related]
28. Protocol for the process evaluation of an intervention to improve antenatal smoking cessation support (MOHMQuit) in maternity services in New South Wales, Australia.
Longman J; Paul C; Cashmore A; Twyman L; Barnes LAJ; Adams C; Bonevski B; Milat A; Passey ME
BMJ Open; 2024 Mar; 14(3):e081208. PubMed ID: 38508650
[TBL] [Abstract][Full Text] [Related]
29. An enquiry based on a standardised questionnaire into knowledge, awareness and preferences concerning the care of familial hypercholesterolaemia among primary care physicians in the Asia-Pacific region: the "Ten Countries Study".
Pang J; Hu M; Lin J; Miida T; Nawawi HM; Park JE; Wu X; Ramli AS; Kim NT; Kwok S; Gonzalez-Santos LE; Su TC; Truong TH; Soran H; Yamashita S; Tomlinson B; Watts GF
BMJ Open; 2017 Oct; 7(10):e017817. PubMed ID: 29074516
[TBL] [Abstract][Full Text] [Related]
30. Universal screening for familial hypercholesterolemia in children: The Slovenian model and literature review.
Groselj U; Kovac J; Sustar U; Mlinaric M; Fras Z; Podkrajsek KT; Battelino T
Atherosclerosis; 2018 Oct; 277():383-391. PubMed ID: 30270075
[TBL] [Abstract][Full Text] [Related]
31. Improving the detection of familial hypercholesterolaemia.
Lan NSR; Martin AC; Brett T; Watts GF; Bell DA
Pathology; 2019 Feb; 51(2):213-221. PubMed ID: 30579649
[TBL] [Abstract][Full Text] [Related]
32. Familial hypercholesterolaemia: a model of care for Australasia.
Watts GF; Sullivan DR; Poplawski N; van Bockxmeer F; Hamilton-Craig I; Clifton PM; O'Brien R; Bishop W; George P; Barter PJ; Bates T; Burnett JR; Coakley J; Davidson P; Emery J; Martin A; Farid W; Freeman L; Geelhoed E; Juniper A; Kidd A; Kostner K; Krass I; Livingston M; Maxwell S; O'Leary P; Owaimrin A; Redgrave TG; Reid N; Southwell L; Suthers G; Tonkin A; Towler S; Trent R;
Atheroscler Suppl; 2011 Oct; 12(2):221-63. PubMed ID: 21917530
[TBL] [Abstract][Full Text] [Related]
33. Can patients be accurately assessed for familial hypercholesterolaemia in primary care?
Bell DA; Kirke AB; Barbour R; Southwell L; Pang J; Burrows S; Watts GF
Heart Lung Circ; 2014 Dec; 23(12):1153-7. PubMed ID: 25065543
[TBL] [Abstract][Full Text] [Related]
34. How Can Implementation Science Improve the Care of Familial Hypercholesterolaemia?
Sarkies M; Jones LK; Pang J; Sullivan D; Watts GF
Curr Atheroscler Rep; 2023 Apr; 25(4):133-143. PubMed ID: 36806760
[TBL] [Abstract][Full Text] [Related]
35. Implications of new clinical practice guidance on familial hypercholesterolaemia for Australian general practitioners.
Brett T; Radford J; Heal C; Hespe CM; Garton-Smith J; Kirke A; Chan DC; Pang J; Watts GF
Aust J Gen Pract; 2021 Sep; 50(9):616-621. PubMed ID: 34462766
[TBL] [Abstract][Full Text] [Related]
36. Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).
; Vallejo-Vaz AJ; De Marco M; Stevens CAT; Akram A; Freiberger T; Hovingh GK; Kastelein JJP; Mata P; Raal FJ; Santos RD; Soran H; Watts GF; Abifadel M; Aguilar-Salinas CA; Al-Khnifsawi M; AlKindi FA; Alnouri F; Alonso R; Al-Rasadi K; Al-Sarraf A; Ashavaid TF; Binder CJ; Bogsrud MP; Bourbon M; Bruckert E; Chlebus K; Corral P; Descamps O; Durst R; Ezhov M; Fras Z; Genest J; Groselj U; Harada-Shiba M; Kayikcioglu M; Lalic K; Lam CSP; Latkovskis G; Laufs U; Liberopoulos E; Lin J; Maher V; Majano N; Marais AD; März W; Mirrakhimov E; Miserez AR; Mitchenko O; Nawawi HM; Nordestgaard BG; Paragh G; Petrulioniene Z; Pojskic B; Postadzhiyan A; Reda A; Reiner Ž; Sadoh WE; Sahebkar A; Shehab A; Shek AB; Stoll M; Su TC; Subramaniam T; Susekov AV; Symeonides P; Tilney M; Tomlinson B; Truong TH; Tselepis AD; Tybjærg-Hansen A; Vázquez-Cárdenas A; Viigimaa M; Vohnout B; Widén E; Yamashita S; Banach M; Gaita D; Jiang L; Nilsson L; Santos LE; Schunkert H; Tokgözoğlu L; Car J; Catapano AL; Ray KK;
Atherosclerosis; 2018 Oct; 277():234-255. PubMed ID: 30270054
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience.
Bell DA; Pang J; Burrows S; Bates TR; van Bockxmeer FM; Hooper AJ; O'Leary P; Burnett JR; Watts GF
Atherosclerosis; 2015 Mar; 239(1):93-100. PubMed ID: 25585028
[TBL] [Abstract][Full Text] [Related]
38. Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care.
Watts GF; Gidding SS; Mata P; Pang J; Sullivan DR; Yamashita S; Raal FJ; Santos RD; Ray KK
Nat Rev Cardiol; 2020 Jun; 17(6):360-377. PubMed ID: 31974482
[TBL] [Abstract][Full Text] [Related]
39. Comparing the performance of the novel FAMCAT algorithms and established case-finding criteria for familial hypercholesterolaemia in primary care.
Qureshi N; Akyea RK; Dutton B; Leonardi-Bee J; Humphries SE; Weng S; Kai J
Open Heart; 2021 Oct; 8(2):. PubMed ID: 34635577
[TBL] [Abstract][Full Text] [Related]
40. Participant experiences of intervention to detect and manage familial hypercholesterolaemia in Australian general practice: A qualitative descriptive study.
Skoss R; Brett T; Bulsara C; Radford J; Heal C; Gill G; Hespe C; Vargas-Garcia C; Li IW; Sullivan DR; Vickery AW; Pang J; Arnold-Reed DE; Watts GF
Aust J Gen Pract; 2022 Sep; 51(9):687-694. PubMed ID: 36045626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
